RXRX logo

RXRX Retained Earnings

Annual Retained Earnings:

-$1.43B-$463.66M(-47.92%)
December 31, 2024

Summary

  • As of today, RXRX annual retained earnings is -$1.43 billion, with the most recent change of -$463.66 million (-47.92%) on December 31, 2024.
  • During the last 3 years, RXRX annual retained earnings has fallen by -$1.03 billion (-257.75%).
  • RXRX annual retained earnings is now -1030.60% below its all-time high of -$126.59 million, reached on December 31, 2019.

Performance

RXRX Retained Earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRXRXbalance sheet metrics

Quarterly Retained Earnings:

-$1.81B-$171.90M(-10.52%)
June 30, 2025

Summary

  • As of today, RXRX quarterly retained earnings is -$1.81 billion, with the most recent change of -$171.90 million (-10.52%) on June 30, 2025.
  • Over the past year, RXRX quarterly retained earnings has dropped by -$649.05 million (-56.12%).
  • RXRX quarterly retained earnings is now -745.31% below its all-time high of -$213.60 million, reached on December 1, 2020.

Performance

RXRX Quarterly Retained Earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRXRXbalance sheet metrics

Retained Earnings Formula

Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid

RXRX Retained Earnings Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year-47.9%-56.1%
3Y3 Years-257.8%-246.2%
5Y5 Years-1030.6%-

RXRX Retained Earnings Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Year-257.8%at low-210.2%at low
5Y5-Year-1030.6%at low-745.3%at low
All-TimeAll-Time-1030.6%at low-745.3%at low

RXRX Retained Earnings History

DateAnnualQuarterly
Jun 2025
-
-$1.81B(-10.5%)
Mar 2025
-
-$1.63B(-14.1%)
Dec 2024
-$1.43B(-47.9%)
-$1.43B(-14.3%)
Sep 2024
-
-$1.25B(-8.3%)
Jun 2024
-
-$1.16B(-9.2%)
Mar 2024
-
-$1.06B(-9.4%)
Dec 2023
-$967.62M(-51.3%)
-$967.62M(-10.6%)
Sep 2023
-
-$874.63M(-11.9%)
Jun 2023
-
-$781.61M(-10.9%)
Mar 2023
-
-$704.88M(-10.2%)
DateAnnualQuarterly
Dec 2022
-$639.56M(-59.9%)
-$639.56M(-9.9%)
Sep 2022
-
-$582.06M(-11.6%)
Jun 2022
-
-$521.62M(-14.4%)
Mar 2022
-
-$456.06M(-14.0%)
Dec 2021
-$400.08M(-87.3%)
-$400.08M(-19.4%)
Sep 2021
-
-$335.15M(-16.5%)
Jun 2021
-
-$287.72M(-17.8%)
Mar 2021
-
-$244.32M(-14.4%)
Dec 2020
-$213.60M(-68.7%)
-
Dec 2020
-
-$213.60M
Dec 2019
-$126.59M
-

FAQ

  • What is Recursion Pharmaceuticals, Inc. annual retained earnings?
  • What is the all-time high annual retained earnings for Recursion Pharmaceuticals, Inc.?
  • What is Recursion Pharmaceuticals, Inc. annual retained earnings year-on-year change?
  • What is Recursion Pharmaceuticals, Inc. quarterly retained earnings?
  • What is the all-time high quarterly retained earnings for Recursion Pharmaceuticals, Inc.?
  • What is Recursion Pharmaceuticals, Inc. quarterly retained earnings year-on-year change?

What is Recursion Pharmaceuticals, Inc. annual retained earnings?

The current annual retained earnings of RXRX is -$1.43B

What is the all-time high annual retained earnings for Recursion Pharmaceuticals, Inc.?

Recursion Pharmaceuticals, Inc. all-time high annual retained earnings is -$126.59M

What is Recursion Pharmaceuticals, Inc. annual retained earnings year-on-year change?

Over the past year, RXRX annual retained earnings has changed by -$463.66M (-47.92%)

What is Recursion Pharmaceuticals, Inc. quarterly retained earnings?

The current quarterly retained earnings of RXRX is -$1.81B

What is the all-time high quarterly retained earnings for Recursion Pharmaceuticals, Inc.?

Recursion Pharmaceuticals, Inc. all-time high quarterly retained earnings is -$213.60M

What is Recursion Pharmaceuticals, Inc. quarterly retained earnings year-on-year change?

Over the past year, RXRX quarterly retained earnings has changed by -$649.05M (-56.12%)
On this page